Brain activity and nerve health study in Lewy body disease
Part of Brain & nervous system, Mental health clinical trials.
This trial looks at brain wave patterns (EEG) and nerve damage in people with Lewy body disease. It uses past data from a study called Alpha-Lewy-MA and a special test (RT-QuIC) to learn more about the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 years or older).
- You took part in the Alpha-Lewy-MA research study before.
- Your sample was tested with the RT-QuIC method as part of that study.
- You had a standard EEG brain wave test at the University Hospital of Strasbourg between January 1, 2012 and January 1, 2020.
- You have not said you do not want to be in this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how brain function changes over time in people with Lewy body disease or Alzheimer's. Researchers will use memory tests, MRI scans, and EEG (a painless brain-wave recording) to track these changes, and you will need a family member or friend to help report on your daily life.
This trial follows people with probable Lewy body dementia over several years to see how the brain changes on MRI and on memory/thinking tests. It may help researchers understand disease progression and improve future care for Lewy body dementia.
This study looks at how to tell people about their test results for alpha-synuclein, a protein linked to Lewy body disease (including Parkinson's disease and certain dementias). It aims to help people understand their diagnosis and the process of sharing these results.
This study is testing whether digital health tools (like wearable sensors) can better track symptoms of certain brain conditions (PSP, DLB, and MCI with Lewy bodies). It aims to improve monitoring and care for people with these conditions.
This study tracks changes in people with Parkinson's disease, other movement disorders, or cognitive decline to find better ways to measure disease progression.
This study tests a medicine called ambroxol, which may slow down the progression of Lewy body dementia. It aims to see if it can improve memory, thinking, and movement symptoms.
Hear when a new Lewy Body Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.